ABSTRACT Three experiments were conducted to test the potencies of nine sources of cholecalciferol using a chick bioassay. The tested products were compared with a Sigma Reference Standard (SRS). All of the diets fed to the chicks were prepared from corn-soybean meal. Each of the products was in premix form containing cholecalciferol. Their physical characteristics reflected the methods used to produce the premixes. They were categorized as spray-dried or drum-dried in the beadlet or flake form. Basal diets without cholecalciferol were used in all experiments. For Experiments 1 and 2, the designs were a 2 × 3 factorial arrangement using three different cholecalciferol products and two levels of 200 and 400 IU/kg dietary cholecalciferol. For both experiments, three additional SRS levels of 600, 800, and 1,000 IU/kg were included in
INTRODUCTION
During the last 50 yr, there is only a single published report on the evaluation of commercially synthesized cholecalciferol preparations using poultry. The studies conducted by Yang et al. (1973) evaluated commercial cholecalciferol preparations with young male turkey poults using corn-soybean meal basal diets. They conducted two separate studies using femoral ash and toe ash as response criteria. Each product had its stated potency, which was derived from chemical analysis. In the first study, of 26 cholecalciferol supplements evaluated, 19 supplements showed potencies above 80%. Six supplements showed lower potencies, of which four showed potencies under 60%. In the second study, all five supplements showed potencies below 80%, of which three had potencies under 60%. They also found that chemical assays overestimated the potencies of some of the cholecalciferol supplements.
Today, the stated potency or activity of a commercial cholecalciferol product is determined by an improved To whom correspondence should be addressed: hedwards@uga.edu.
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the studies as positive controls as there is a possibility that the cholecalciferol products being tested may exhibit activity higher than the amount stated. In Experiment 3, a 3 × 4 factorial arrangement was used, which was represented by three cholecalciferol products and four levels of dietary cholecalciferol at 150, 300, 600, and 1,200 IU/kg. By using the slope ratio analysis, the potencies of the products from the three experiments were between 86 and 118%. In Experiment 3, the requirement of chicks for cholecalciferol using the three tested products, as determined by a nonlinear regression model based on bone ash, were 843 ± 85, 911 ± 106, and 986 ± 131 IU/kg of diet as compared with 915 ± 82 IU/kg when using the SRS. The results from these studies indicate that the chemical assays used to determine the cholecalciferol activity of these products were very reliable. chemical assay. In the poultry industry, the potencies of these cholecalciferol preparations are still of great importance because the occurrence of skeletal disorders in commercial broilers is still common (Riddell, 1991) . The risk of toxicity is very minimal because it is beyond practical means to reach the dietary cholecalciferol toxicity levels of 400,000 IU/kg (Morissey et al., 1977) and 500,000 IU/kg (Taylor et al., 1968) .
Commercial cholecalciferol preparations are available in several physical forms and preparations. Commercial preparations for animal feeds are usually spray-dried or drum-dried and are in beadlet or flake forms. These products are usually made from the same original cholecalciferol product. A study was undertaken to evaluate the efficacy of several commercial cholecalciferol preparations using broiler chicks and a corn-soybean meal diet.
MATERIALS AND METHODS

General Procedure
Three experiments were conducted for a period of 16 d using 1-d-old broiler chicks. Experiments 1 and 2 were conducted using male Ross × Ross chicks from a commercial hatchery 3 , and, in Experiment 3, mixed sex Peterson × Hubbard chicks from another commercial hatchery 4 were used. The corn-soybean meal basal diet used is shown in Table 1 . All experiments were conducted in electrically heated wire mesh-floored battery brooders 5 ; feed and water were always available. Ultraviolet irradiation was eliminated from the chick room by completely covering glass windows with opaque plastic sheets and by fitting Arm-a-Lite 6 sleeves to all of the fluorescent fixtures in the room and battery brooders (Edwards et al., 1994) . The fluorescent lights were on 24 h each day. The temperature of the room was maintained at 22 C.
At the termination of the experiments, one bird from each pen was selected randomly, and a blood sample was obtained by heart puncture for plasma total Ca 7 content. The birds were weighed by pens, and their feed consumption was recorded. They were then killed by carbon dioxide asphyxiation and examined at random for rickets. A longitudinal cut was made across the right tibia, and diagnosis for rickets was made based on the width of the growth plate band and its appearance (Edwards et al., 1994) . Bone ash on a fat-free dry basis (Association of Official Analytical Chemists, 1995) was determined on the left tibia.
The pure crystalline cholecalciferol designated by Sigma Chemical Co.
8 as Sigma Reference Standard (SRS) meets or exceeds all U.S. Pharmacopoeia specifications and was used as the standard in all of these studies. This crystalline cholecalciferol was diluted with propylene glycol to produce a dilution of 10 µg/mL, which was used to mix diets containing 150 to 1,000 IU/kg cholecalciferol, and 20 µg/mL, which was used to mix diets containing over 1,000 IU/kg cholecalciferol. Nine different commercially available cholecalciferol sources were evaluated in these experiments. They were designated as follows: A) spray-dried beadlet AD 3 650/325 (indicates product contained both vitamin A and cholecalciferol at concentrations of 630,000 IU/g and 325,000 IU/g) diluted to 4,063 IU/g, B) spray-dried beadlet D 3 500 diluted to 6,250 IU/g, C) drum-dried flake D 3 1,000 diluted to 12,500 IU/g, D) drum-dried flake D 3 1,000 diluted to 12,500 IU/g, E) spray-dried beadlet AD 3 650/325 diluted to 4,063 IU/g, F) spray-dried beadlet D 3 500 diluted to 6,250 IU/g, G) spray-dried beadlet AD 3 500/100 diluted to 600 IU/g, H) spray-dried beadlet D 3 500 diluted to 600 IU/g, and I) drum-dried flake D 3 1,000 diluted to 600 IU/g. These products were diluted with soybean protein to yield the concentrations of cholecalciferol indicated and to allow accurate weighing of the small amounts that were added to the relatively small batches of feed mixed. Vitamin A (as all-trans-retinyl acetate) was added to the diets to make them all equal at a level of 10,000 IU/kg.
Analysis of variance and regression analysis were computed using the General Linear Models procedure of SAS (SAS Institute, 1990) . Relative potencies of the tested products were determined by a slope ratio method using the first two supplementation levels of cholecalciferol. The requirement for cholecalciferol based on bone ash was determined for the standards in Experiments 1, 2, and 3 and for all of the tested products in Experiment 3 using a nonlinear regression model (Rogers et al., 1987) .
Experiments 1 and 2
Experiments 1 and 2 were conducted to evaluate the potency of six commercial preparations of cholecalciferol. The three products tested in Experiment 1 (A, B, and C) were different from the three products in Experiment 2 (D, E, and F). The SRS was used as the reference standard. The design for both experiments was a 3 × 2 factorial arrangement consisting of three different cholecalciferol products and two dietary cholecalciferol levels (200 and 400 IU/kg). These levels could produce a measurable magnitude of response (Kasim, 1998) . In both experiments, additional levels of SRS at 600, 800, and 1,000 IU/kg were included in case the commercial sam-ples tested contained much more activity than indicated by their chemical analysis. A total of 240 chicks was used in both experiments with four replicated pens containing 10 chicks each.
Experiment 3
Another three commercial preparations of cholecalciferol (G, H, and I) were evaluated and compared with the SRS. All of the cholecalciferol preparations were tested at four dietary levels of 0, 150, 300, 600, and 1,200 IU/kg using a 4 × 4 factorial arrangement. All treatments were replicated three times except for the treatments containing 150 IU/kg from the tested preparations, which were replicated twice. Each treatment pen consisted of 10 chicks.
RESULTS
Experiment 1
The responses of broiler chicks fed three different cholecalciferol products is presented in Table 2 . The 16-d BW was significantly influenced by the types and levels of cholecalciferol products fed. With the exception of 200 IU/kg dietary cholecalciferol treatment from Product A, chick BW were greater using the tested products compared with the SRS at the corresponding levels. Plasma Ca and bone ash were significantly influenced by the Values are means of four pens per treatment. Each pen initially contained 10 chicks that were used to obtain all of the above means except plasma Ca, for which one chick per pen was used. type of cholecalciferol products used, but only bone ash was influenced by the level of inclusion in the feeds. The commercial products promoted greater levels of plasma Ca and bone ash at 200 IU/kg of dietary cholecalciferol than did the SRS cholecalciferol at the similar treatment level. However, increasing dietary cholecalciferol supplementation to 400 IU/kg did not affect the plasma Ca but significantly affected bone ash responses. Higher dietary supplementation of cholecalciferol using Products A and C, but not Product B, improved bone ash. Increasing the dietary cholecalciferol levels reduced the incidence and severity of rickets. Type of cholecalciferol products did not affect incidence or severity of rickets, but there was a two-way interaction on the severity of rickets. The potencies of the products as determined by slope ratio analysis using percentage bone ash vs dietary cholecalciferol levels at 0, 200, and 400 IU/kg are 111, 118, and 105% for Products A, B, and C, respectively.
Experiment 2
The response of broiler chicks fed three different cholecalciferol products is presented in Table 3 . Neither type of product or level of cholecalciferol fed influenced the 16-d BW and gain to feed ratio. However, there was a significant two-way interaction effect of product types and dietary cholecalciferol levels on gain to feed ratio. Dietary cholecalciferol levels, but not the type of product used in the feed, significantly influenced plasma Ca. The Values are means of four pens per treatment. Each pen initially contained 10 chicks that were used to obtain all of the above means except plasma Ca, for which one chick per pen was used. type of cholecalciferol product used did not affect the bone ash response. Bone ash responses were improved consistently by increasing dietary cholecalciferol levels when using all cholecalciferol products. A two-way interaction effect on bone ash was significant. Type of cholecalciferol product fed significantly influenced the incidence and severity of rickets. Increasing cholecalciferol supplementation, as in Experiment 1, significantly reduced the incidence and severity of rickets. There was a two-way interaction effect on the incidence and severity of rickets. The potencies of the products, determined by slope ratio analysis using percentage bone ash vs dietary cholecalciferol levels at 0, 200, and 400 IU/kg are 86, 110, and 86% for Products D, E, and F, respectively.
Experiment 3
The effect of feeding broiler chicks with three different cholecalciferol products at four supplementary levels is shown in Table 4 . The only significant effect using the different cholecalciferol products was on plasma Ca. Increasing the dietary cholecalciferol levels of all product types significantly improved 16-d BW, gain to feed ratio, plasma Ca, and bone ash and reduced the incidence and severity of rickets. There was no two-way interaction effect between product types and dietary cholecalciferol level on any of the response criteria. The potencies of the products as determined by slope ratio analysis using percentage bone ash vs dietary cholecalciferol levels at 0, 150, and 300 IU/kg are 107, 104, and 92% for products G, H, and I, respectively.
DISCUSSION
These experiments indicate that all of the nine sources of cholecalciferol tested had a biological potency close to their guaranteed content. These biological potencies as determined by slope ratio analysis were 111, 118, 105, 86, 110, 86, 107, 104, and 92% for Products A through I, respectively. In all of the experiments, the only treatment that was out of line or unusual was that for 200 IU/kg of Product B. The 16-d BW, plasma Ca, bone ash, and incidence of rickets all indicated that a higher level of cholecalciferol was fed. The most likely explanation of these results is that there was incomplete mixing of the cholecalciferol dilution for this product, and a larger amount was supplemented than had been intended.
The bone ash response in Experiment 3 at various levels of dietary cholecalciferol supplementation indicated that the difference in potencies among tested products may actually narrow with ascending levels of cholecalciferol and their potency may become similar when bone ash approached maximum. The relative potencies of products G, H, and I as determined by slope ratio analysis became closer to 100% (from 107 to 99%, 104 to 96%, and 92 to 96%, respectively) when the slope ratio analysis included the 600 IU/kg dietary cholecalciferol level. Because these changes result in minor adjustments Values are means of three pens per treatment, except for cholecalciferol levels at 150 IU/kg, which are means of two pens. Each pen initially contained 10 chicks that were used to obtain all of the above means except plasma Ca, for which one chick per pen was used. in relative potencies, supplementation levels of cholecalciferol in the feeds may not be a critical factor in determining the potencies of these products. These studies showed that chemical assays conducted by the manufacturers to measure the activity of the cholecalciferol products were very reliable and truly reflect the potential of the products when given to chicks. A nonlinear regression model characterized by an ascending quadratic and a plateau was employed to determine the requirement for cholecalciferol by the chicks (Table 5 ) when consuming the SRS (Experiments 1, 2, and 3) and the tested products (Experiment 3) using percentage bone ash as a criteria. The dietary cholecalciferol requirement of broiler chicks for maximum bone ash in these studies ranged from 804 to 1,131 IU/kg. The difference in the magnitude of the bone ash responses between Experiments 1 and 2 suggests that factors such as dam effects and certain inherent properties of feed ingredients might be important.
